Skip to main content
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.97
-0.14 (-0.87%)
At close: Feb 27, 2026, 4:00 PM EST
16.06
+0.09 (0.56%)
After-hours: Feb 27, 2026, 7:14 PM EST

Nurix Therapeutics Revenue

In the fiscal year ending November 30, 2025, Nurix Therapeutics had annual revenue of $83.98M with 53.95% growth. Nurix Therapeutics had revenue of $13.58M in the quarter ending November 30, 2025, with 2.21% growth.

Revenue (ttm)
$83.98M
Revenue Growth
+53.95%
P/S Ratio
19.56
Revenue / Employee
$264,921
Employees
317
Market Cap
1.64B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 202583.98M29.43M53.95%
Nov 30, 202454.55M-22.44M-29.15%
Nov 30, 202376.99M38.36M99.31%
Nov 30, 202238.63M8.88M29.84%
Nov 30, 202129.75M11.93M66.95%
Nov 30, 2020 Pro Pro Pro
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 868.45M
Ardelyx 407.32M
Immunocore Holdings 400.02M
Intellia Therapeutics 67.67M
Relay Therapeutics 15.36M
Oculis Holding AG 992.00K
Revenue Rankings

NRIX News

More News